Tag: carotid artery disease
Initial cases indicate lithotripsy can help TCAR expand into high-risk patients
Lithotripsy may hold the key to enabling more carotid artery disease patients who require calcification treatment to undergo stent placement via a transcarotid artery...
AI demonstrates potential to detect carotid artery disease on duplex ultrasound
A prospective study has demonstrated the potential feasibility, applicability and accuracy held by artificial intelligence (AI) in the detection of carotid artery disease on...
Silk Road Medical announces first patient enrolled in ROADSTER 3 post-approval...
Silk Road Medical has announced enrolment of the first patient in ROADSTER 3, which the company claims is the the first prospective, multicentre, single-arm...
Silk Road to evaluate TCAR in standard surgical risk patients with...
Silk Road Medical today announced a post-market study to evaluate the transcarotid artery revascularisation (TCAR) system in the treatment of standard surgical risk patients...
InspireMD announces the inclusion of its CGuard carotid stent in CREST-2...
InspireMD has announced that its CGuard embolic prevention stent system (EPS) will be included as a device option for stenting in CREST-2 (Carotid revascularisation...
Study highlights need to extend scope of cerebrovascular health disparities research
A new research letter in Stroke outlines use of the novel National Institutes of Health (NIH) ‘All of Us’ research programme dataset of diverse...
SVS releases updated clinical practice guidelines on extracranial cerebrovascular disease
The Society for Vascular Surgery (SVS) has released updated clinical practice guidelines accompanied by an implementation document on the management of patients with extracranial...
Favorable outcomes with TCAR versus carotid endarterectomy in patients with carotid...
Silk Road Medical announced the presentation of real-world data for the treatment of patients with carotid artery disease at risk for stroke at the...
Regulatory and reimbursement approval of CGuard EPS in Australia
CGuard Embolic Prevention System (EPS) (InspireMD) has been granted regulatory approval by the Therapeutic Goods Administration (part of the Australian Government’s Department of Health)...
